Santé des yeux avec astaxanthine
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-Dihydroxy-4,4'-diketo-bêta-carotène | 9 mg | Not calculated |
| Mélange de concentré de tocophérol Source : Helianthus annuus - Graine | 75 mg | Not calculated |
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 15 mg | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 0.7 mg | Not calculated |
Non-medicinal ingredients
Triglycérides à chaîne moyenne, Hypromellose, farine de riz, Dextrine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Aide à améliorer la densité optique du pigment maculaire. Aide à préserver la vision/la santé des yeux dans certaines conditions (associées au dommage par le soleil) telles que les cataractes et la dégénérescence maculaire reliée à l'âge. Aide à réduire le risque de développer des cataractes. Source d'antioxydants/Fournit des antioxydants (pour le maintien d'une bonne santé). Source d'antioxydants/Fournit des antioxydants pour le maintien de la santé oculaire/des yeux. Source d'(un) antioxydant(s)/Fournit (un) (des) antioxydant(s) qui aide(nt) à combattre/à protéger (les cellules) contre/à réduire (les effets oxydatifs des/les dommages oxydatifs causés par/les dommages cellulaires causés par) les radicaux libres. Aide à réduire la fatigue oculaire (asthénopie).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- MJ Nutra
- NPN or DIN-HM
- 80145734
- Status
- Active licence
- Licence date
- 27 November 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80145734
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Santé des yeux avec astaxanthine (MJ Nutra): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80145734-sante-des-yeux-avec-astaxanthine, updated 27 November 2025.